| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 7,709,000 | 7,564,000 | 8,808,000 | 8,393,000 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 7,709,000 | 7,564,000 | 8,808,000 | 8,393,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,711,000 | 6,873,000 | 10,200,000 | 4,885,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,000) | 691,000 | (1,392,000) | 3,508,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (2,000) | 691,000 | (1,392,000) | 3,508,000 | | Interest Expense | (637,000) | 637,000 | (2,388,000) | 2,388,000 | | Income Before Tax | 635,000 | 54,000 | 996,000 | 1,120,000 | | Income Tax Expense | 66,000 | 29,000 | 182,000 | 316,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 593,000 | 68,000 | 860,000 | 871,000 | | | Non-recurring Events | | Discontinued Operations | (3,000) | 1,000 | 11,000 | (4,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 590,000 | 69,000 | 871,000 | 867,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $590,000 | $69,000 | $871,000 | $867,000 |
|
1.49% Nasdaq 
0.27%
Income Statement
